Buccal, polar and non-polar spray or capsule containing drugs for treating pain
First Claim
1. A propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
- an active compound in an amount of between 0.001 and 60 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof; and
a polar solvent in an amount between 30 and 99 percent by weight of the total composition.
3 Assignments
0 Petitions
Accused Products
Abstract
Buccal aerosol sprays or capsules using polar and non-polar solvent have now been developed which provide biologically active compounds for rapid absorption through the oral mucosa, resulting in fast onset of effect. The buccal polar compositions of the invention comprise formulation I: aqueous polar solvent, active compound, and optional flavoring agent; formulation II: aqueous polar solvent, active compound, optionally flavoring agent, and propellant; formulation III: non-polar solvent, active compound, and optional flavoring agent; and formulation IV: non-polar solvent, active compound, optional flavoring agent, and propellant.
153 Citations
55 Claims
-
1. A propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
-
an active compound in an amount of between 0.001 and 60 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof; and
a polar solvent in an amount between 30 and 99 percent by weight of the total composition. - View Dependent Claims (2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14)
-
-
15. A buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
-
an active compound in an amount of between 0.1 and 25 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof;
a polar solvent in an amount between 10 and 97 percent by weight of the total composition; and
a propellant in an amount between 2 and 10 percent by weight of the total composition, wherein said propellant is a C3 to C8 hydrocarbon of linear or branched configuration. - View Dependent Claims (16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29)
-
-
30. A propellant free buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
-
an active compound in an amount between 0.005 and 55 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof; and
a non-polar solvent in an amount between 30 and 99 percent by weight of the total composition. - View Dependent Claims (31, 32, 33, 34, 35, 36, 37, 38, 39, 40)
-
-
41. A buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
-
an active compound in an amount between 0.05 and 50 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof; and
a non-polar solvent in an amount between 19 and 85 percent by weight of the total composition; and
a propellant in an amount between 5 and 80 percent by weight of the total composition, wherein said propellant is a C3 to C8 hydrocarbon of linear or brancehed configuration. - View Dependent Claims (42, 43, 46, 47, 48, 49, 50, 51, 52, 53, 54, 55)
-
-
44. A buccal spray composition for transmucosal administration of a pharmacologically active compound comprising:
-
an active compound in an amount between 0.01 and 40 percent by weight of the total composition selected from the group consisting of anti-opioid agents, anti-migraine agents, pain control agents, anesthetics, and mixtures thereof; and
a non-polar solvent in an amount between 25 and 89 percent by weight of the total composition;
a propellant in an amount between 10 and 70 percent by weight of the total composition, wherein said propellant is a C3 to C8 hydrocarbon of linear or brancehed configuration; and
A flavoring agent is present in an amount between 1 and 8 percent by weight of the total composition. - View Dependent Claims (45)
-
Specification